# OnCo record molecularmd (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/molecularmd/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "molecularmd" ;
  schema:name "MolecularMD"@en ;
  schema:alternateName "MolecularMD Corporation"@en, "Molecularmd Corporation"@en ;
  schema:description "Portland molecular diagnostics laboratory, owned by ICON plc since 2019, that holds the FDA clearance for the MRDx BCR-ABL test in chronic myeloid leukaemia."@en ;
  schema:url <https://onco.cc/companies/molecularmd/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K173492>, <https://www.iconplc.com/news-events/press-releases/icon-acquires-molecularmd> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/cml/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/> ;
  onco:drugs <https://onco.cc/drugs/mrdx-bcr-abl/> .